New drug ME3241 put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study is testing a new drug called ME3241 in healthy adults aged 18 to 55. The main goal is to check if it is safe and how the body processes it. About 104 participants will receive either the drug or a placebo. This study does not aim to treat any disease.
Phase: PHASE1 • Sponsor: Meiji Pharma USA Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC